Abstract Background Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID). a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing is needed to improve their engagement in the HCV care cascade. We used data from a cross-sectional survey of people who inject drugs. https://www.chincoponydrillteam.com/product-category/dog/